In simple terms, Horizon Therapeutics Public Limited Company has 228.995 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.752% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.141%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.120%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.047% return, is a testament to Horizon Therapeutics Public Limited Company's adeptness in optimizing resource deployment. Horizon Therapeutics Public Limited Company's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.085%. Furthermore, the proficiency of Horizon Therapeutics Public Limited Company in capital utilization is underscored by a remarkable 0.061% return on capital employed.
Stock Prices
Horizon Therapeutics Public Limited Company's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $115.7, while its low point bottomed out at $115.19. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Horizon Therapeutics Public Limited Company's stock market.
Liquidity Ratios
Analyzing HZNP liquidity ratios reveals its financial health of the firm.
The current ratio of 427.38% gauges short-term asset coverage for liabilities.
The quick ratio (350.22%) assesses immediate liquidity, while the cash ratio (268.57%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
427.38%
Quick Ratio
350.22%
Cash Ratio
268.57%
Profitability Ratios
HZNP profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 12.18% underscores its earnings before tax deductions.
The effective tax rate stands at 1.32%, revealing its tax efficiency.
The net income per EBT, 98.68%, and the EBT per EBIT, 86.46%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 14.09%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
12.18%
Effective Tax Rate
1.32%
Net Income per EBT
98.68%
EBT per EBIT
86.46%
EBIT per Revenue
14.09%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 4.27, it details the span from stock purchase to revenue.
The 4 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 3 cash conversion cycle and 507.99% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
350
Days of Inventory Outstanding
69
Operating Cycle
140.67
Days of Payables Outstanding
35
Cash Conversion Cycle
106
Receivables Turnover
5.08
Payables Turnover
10.56
Inventory Turnover
5.30
Fixed Asset Turnover
10.06
Asset Turnover
0.39
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.45, and free cash flow per share, 3.87, depict cash generation on a per-share basis.
The cash per share value, 10.67, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.29, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
4.45
Free Cash Flow per Share
3.87
Cash per Share
10.67
Operating Cash Flow Sales Ratio
0.29
Free Cash Flow to Operating Cash Flow Ratio
0.87
Cash Flow Coverage Ratio
0.41
Short Term Coverage Ratio
65.04
Capital Expenditure Coverage Ratio
7.74
Dividend Paid and Capex Coverage Ratio
7.74
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 27.50%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.48, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 32.37%, and total debt to capitalization, 32.50%, ratios shed light on its capital structure.
An interest coverage of 7.47 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
27.50%
Debt Equity Ratio
0.48
Long Term Debt to Capitalization
32.37%
Total Debt to Capitalization
32.50%
Interest Coverage
7.47
Cash Flow to Debt Ratio
0.41
Company Equity Multiplier
1.75
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 15.43, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 2.22, reflects the portion of profit attributed to each share.
The book value per share, 21.56, represents the net asset value distributed per share, while the tangible book value per share, 2.49, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
15.43
Net Income Per Share
2.22
Book Value Per Share
21.56
Tangible Book Value Per Share
2.49
Shareholders Equity Per Share
21.56
Interest Debt Per Share
11.25
Capex Per Share
-0.54
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 12.48%, indicates top-line expansion, while the gross profit growth, 11.39%, reveals profitability trends.
EBIT growth, 13.68%, and operating income growth, 13.68%, offer insights into operational profitability progression.
The net income growth, -2.43%, showcases bottom-line expansion, and the EPS growth, -3.80%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
12.48%
Gross Profit Growth
11.39%
EBIT Growth
13.68%
Operating Income Growth
13.68%
Net Income Growth
-2.43%
EPS Growth
-3.80%
EPS Diluted Growth
-2.20%
Weighted Average Shares Growth
1.58%
Weighted Average Shares Diluted Growth
-0.19%
Operating Cash Flow Growth
21.50%
Free Cash Flow Growth
24.47%
10-Year Revenue Growth per Share
3036.29%
5-Year Revenue Growth per Share
144.63%
3-Year Revenue Growth per Share
122.89%
10-Year Operating CF Growth per Share
378.45%
5-Year Operating CF Growth per Share
219.61%
3-Year Operating CF Growth per Share
135.57%
10-Year Net Income Growth per Share
200.78%
5-Year Net Income Growth per Share
190.44%
3-Year Net Income Growth per Share
-27.34%
10-Year Shareholders Equity Growth per Share
712.02%
5-Year Shareholders Equity Growth per Share
264.38%
3-Year Shareholders Equity Growth per Share
85.31%
5-Year Dividend per Share Growth per Share
-100.00%
Receivables Growth
6.89%
Inventory Growth
-24.88%
Asset Growth
5.03%
Book Value per Share Growth
6.87%
Debt Growth
-0.33%
R&D Expense Growth
1.38%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 26,980,276,283.8, captures the company's total value, considering both debt and equity.
Income quality, 2.41, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.42, gauges operational efficiency, while the research and development to revenue, 12.07%, highlights investment in innovation.
The ratio of intangibles to total assets, 49.21%, indicates the value of non-physical assets, and capex to operating cash flow, -10.04%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
26,980,276,283.8
Income Quality
2.41
Sales General and Administrative to Revenue
0.42
Research and Development to Revenue
12.07%
Intangibles to Total Assets
49.21%
Capex to Operating Cash Flow
-10.04%
Capex to Revenue
-3.48%
Capex to Depreciation
-32.35%
Stock-Based Compensation to Revenue
5.02%
Graham Number
32.79
Return on Tangible Assets
11.26%
Graham Net Net
-4.55
Working Capital
2,703,706,000
Tangible Asset Value
586,859,000
Net Current Asset Value
-389,599,000
Invested Capital
1
Average Receivables
654,561,000
Average Payables
92,962,500
Average Inventory
197,644,500
Days Sales Outstanding
68
Days Payables Outstanding
62
Days of Inventory On Hand
67
ROIC
8.00%
ROE
0.10%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.12, and the price to book ratio, 5.12, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 7.31, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 29.39, and price to operating cash flows, 26.14, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
5.12
Price to Book Ratio
5.12
Price to Sales Ratio
7.31
Price Cash Flow Ratio
26.14
Price Earnings to Growth Ratio
0.57
Enterprise Value Multiple
27.73
Price Fair Value
5.12
Price to Operating Cash Flow Ratio
26.14
Price to Free Cash Flows Ratio
29.39
Price to Tangible Book Ratio
5.28
Enterprise Value to Sales
7.43
Enterprise Value Over EBITDA
24.20
EV to Operating Cash Flow
21.45
Earnings Yield
1.95%
Free Cash Flow Yield
4.23%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
